Co-beneldopa (Benserazide/levodopa) Prescribing at SAFFRON HEALTH PARTNERSHIP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
296
Total Quantity
38.0K
NHS Cost
£2.8K
vs National Avg
+95.8%
SAFFRON HEALTH PARTNERSHIP prescribed 296 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £2,771 to the NHS. This is 95.8% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
28
Jul 2026
18
Jul 2026
29
Jul 2026
18
Jul 2026
25
Jul 2026
22
Jul 2026
21
Jul 2026
31
Jul 2026
27
Jul 2026
28
Jul 2026
26
Jul 2026
23
Prescribing Details
| Total Items | 296 |
|---|---|
| Total Quantity | 38,000 |
| Total NHS Cost | £2,771 |
| Presentations | 11 different forms |
| vs National Average | +95.8% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 296 items |
|---|---|
| National average per practice | 151 items |
| Difference | +95.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.